Biochemical markers in ovarian cancer.
Fucose and sialic acid were measured in 41 patients with malignant ovarian tumors and in 25 patients with benign tumors. Supplementary, serial determinations done in 20 patients, with advanced ovarian cancer subjected to primary or secondary surgery (optimal tumor debulking) and subsequent chemotherapy enables to suggest the possibility to use these parameters as markers in monitoring ovarian cancer evolution and treatment.
D003131:Combined Modality Therapy; D005260:Female; D005643:Fucose / Q000097:blood*; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D019158:N-Acetylneuraminic Acid; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000601:surgery; D011379:Prognosis; D012794:Sialic Acids / Q000097:blood*
D012794:Sialic Acids; D005643:Fucose; D019158:N-Acetylneuraminic Acid